Literature DB >> 30833838

Spontaneous Resolution of Residual Shunting in 2 Compromised Patients after Amplatzer Occlusion of Postinfarction Ventricular Septal Defects.

Takashi Yanagiuchi, Norio Tada, Taro Suchi, Yukiko Mizutani, Takashi Matsumoto, Mie Sakurai, Tatsushi Ootomo.   

Abstract

Ventricular septal defect (VSD) is a rare, potentially fatal complication of acute myocardial infarction. When surgical closure is contraindicated, transcatheter closure may be an alternative. Residual shunting after transcatheter closure of postinfarction VSDs has been reported; however, we found few cases of this in patients who also had severe heart failure or hemolysis. We report 2 closures of postinfarction VSDs with use of the Amplatzer Septal Occluder. Both elderly patients-one with severe heart failure, one with persistent hemolysis, and neither a surgical candidate-had high-velocity residual shunting through the occluders. We intensively managed the patients' conditions and used angiography and transthoracic echocardiography to record the gradual disappearance of each shunt over 4 months-the first such serial monitoring of which we are aware. We think that even substantial shunting in the presence of severe heart failure or hemolysis can eventually resolve spontaneously, assuming effective management of the concomitant medical conditions.

Entities:  

Keywords:  Aged; heart septal defects, ventricular/complications/diagnostic imaging/therapy; myocardial infarction/therapy; percutaneous coronary intervention/instrumentation; septal occluder device; time factors; treatment outcome; ventricular septal rupture/therapy

Mesh:

Year:  2019        PMID: 30833838      PMCID: PMC6379016          DOI: 10.14503/THIJ-17-6416

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  10 in total

1.  Images in cardiovascular medicine. Incomplete endothelialization and late development of acute bacterial endocarditis after implantation of an Amplatzer septal occluder device.

Authors:  Timothy C Slesnick; Alan W Nugent; Charles D Fraser; Bryan C Cannon
Journal:  Circulation       Date:  2008-05-06       Impact factor: 29.690

2.  Percutaneous closure of post-infarction ventricular septal defect using an Amplatzer septal occluder.

Authors:  Norio Tada; Kaname Takizawa; Mie Sakurai; Genya Yaginuma; Naoto Inoue; Taiichiro Meguro
Journal:  Cardiovasc Interv Ther       Date:  2012-12-07

3.  Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.

Authors:  B S Crenshaw; C B Granger; Y Birnbaum; K S Pieper; D C Morris; N S Kleiman; A Vahanian; R M Califf; E J Topol
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

4.  Transcatheter closure of atrial septal defects. Experimental studies.

Authors:  J E Lock; J J Rome; R Davis; S Van Praagh; S B Perry; R Van Praagh; J F Keane
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

5.  Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder.

Authors:  Mark S Spence; John D Thomson; Naomi Weber; Shakeel A Qureshi
Journal:  Catheter Cardiovasc Interv       Date:  2006-05       Impact factor: 2.692

6.  Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

Authors:  V Menon; J G Webb; L D Hillis; L A Sleeper; R Abboud; V Dzavik; J N Slater; R Forman; E S Monrad; J D Talley; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

7.  Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up.

Authors:  M Demkow; W Ruzyllo; C Kepka; Z Chmielak; M Konka; Z Dzielinska; J Wilczynski; Z Juraszynski
Journal:  EuroIntervention       Date:  2005-05       Impact factor: 6.534

8.  Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry.

Authors:  Ralf Holzer; David Balzer; Zahid Amin; Carlos E Ruiz; Jeffrey Feinstein; John Bass; Michael Vance; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2004-02       Impact factor: 2.692

9.  Late bacterial endocarditis of an amplatzer atrial septal defect occluder device.

Authors:  Firas Zahr; William E Katz; Yoshiya Toyoda; William D Anderson
Journal:  Am J Cardiol       Date:  2010-01-15       Impact factor: 2.778

10.  Immunohistochemical characterization of neotissues and tissue reactions to septal defect-occlusion devices.

Authors:  Rudi Foth; Thomas Quentin; Ina Michel-Behnke; Manfred Vogt; Thomas Kriebel; Anne Kreischer; Wolfgang Ruschewski; Thomas Paul; Matthias Sigler
Journal:  Circ Cardiovasc Interv       Date:  2009-02-20       Impact factor: 6.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.